TrialAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2020

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study.

Haiyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.